page-template,page-template-blog-masonry,page-template-blog-masonry-php,page,page-id-15,stockholm-core-1.1,select-child-theme-ver-1.0.0,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,fs-menu-animation-line-through,popup-menu-text-from-top,wpb-js-composer js-comp-ver-6.0.3,vc_responsive


Hippos is focused specifically on healthcare delivery, a growing segment giving rise to new players and challenging incumbents as healthcare in this country and globally is redefined by better value, quality and access.

healthcare consolidation corporate winners losers

Healthcare Consolidation Will Lead to Corporate Winners and Losers

The healthcare sector has grown to an astonishing $3.2 trillion industry and is expected to climb to $3.7 trillion by 2018. The marketplace is expanding, driven by big changes in expectations for performance and an influx of an estimated 17 million newly insured individuals through

drug pricing debate hippos healthcare

How Pharma Can Respond to the Drug Pricing Debate

While drug pricing transparency is not a topic that is easily explained, it is the topic when it comes to pharmaceutical access, an unavoidable focus that discussions on healthcare continue to highlight. Thus, the question becomes: Is it possible for a pharmaceutical company to usher

best healthcare presentations Hippos Healthcare

What I Learned This Year About The Best Healthcare Presentations

For the first half of this year, I attended many healthcare conferences and watched many healthcare presentations made by all types of organizations from consultants, pharmaceutical companies and health systems, to government entities, healthcare management groups and start-ups. My goal was self-education on healthcare, but